ACTG Community Constituency Group

ACTG Community Constituency Group
Name	ACTG Community Constituency Group
Formation	1980s
Headquarters	United States
Type	Community constituency group
Purpose	Community representation in clinical trials

ACTG Community Constituency Group

The ACTG Community Constituency Group serves as a representative community body connected to the AIDS Clinical Trials Group, engaging stakeholders from National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, Elizabeth Glaser Pediatric AIDS Foundation, and other public health institutions. It liaises with clinical investigators, pharmaceutical companies such as Gilead Sciences, Merck & Co., and ViiV Healthcare, and civil society organizations including ACT UP, Human Rights Campaign, and The Well Project to influence study design, informed consent, and trial enrollment. Members interact with regulatory bodies like the Food and Drug Administration and standards-setting organizations like the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

History

The group emerged amid advocacy networks associated with the HIV/AIDS epidemic during the 1980s and 1990s, contemporaneous with campaigns led by Larry Kramer, Jesse Milan Jr., and Peter Staley. It developed alongside clinical trial initiatives such as the AIDS Clinical Trials Group and contemporaneous research consortia like the International AIDS Society and National Institute of Allergy and Infectious Diseases. Early interactions involved activists from ACT UP and community partners linked to the Ryan White CARE Act implementation, shaping community advisory models found in programs sponsored by National Institutes of Health and philanthropic funders like the Bill & Melinda Gates Foundation.

Mission and Goals

The group's mission centers on equitable participation in trials, safety oversight, and culturally competent engagement with populations affected by HIV/AIDS epidemic, including collaborations with organizations such as AmFAR, Treatment Action Campaign, Global Fund to Fight AIDS, Tuberculosis and Malaria, and Elizabeth Glaser Pediatric AIDS Foundation. Goals include improving trial access for populations represented by Black Panther Party-era health initiatives and contemporary advocacy groups like Black AIDS Institute, ensuring ethical standards endorsed by the Belmont Report and aligning with guidance from the World Health Organization and UNAIDS.

Organizational Structure

The constituency operates through elected and appointed representatives drawn from clinical sites affiliated with the AIDS Clinical Trials Group, community-based organizations like Fenway Health and House Ball Community programs, and academic partners such as Columbia University, Harvard University, and Johns Hopkins University. Governance includes steering committees, working groups, and liaisons to protocol teams and institutional review boards associated with institutions like Massachusetts General Hospital and University of California, San Francisco. Membership pathways mirror community advisory board models used by National Cancer Institute outreach programs and patient advocacy structures in organizations like Susan G. Komen.

Activities and Programs

The group participates in community education, recruitment strategies, and protocol review, coordinating with clinical trial units at centers like Fred Hutchinson Cancer Research Center, Mount Sinai Health System, and University of North Carolina at Chapel Hill. Programs include capacity-building workshops similar to those run by Doctors Without Borders, community town halls modeled on events by AIDS Vaccine Advocacy Coalition, and resource development aligned with guidance from Centers for Disease Control and Prevention. Activities also involve input on pharmacovigilance processes with manufacturers including GlaxoSmithKline and collaborations with networks such as the HIV Prevention Trials Network.

Partnerships and Advocacy

Partnerships extend to advocacy groups including National Black Church Initiative, Lambda Legal, Sierra Club-adjacent health coalitions, and international partners like Médecins Sans Frontières and Partners In Health. The constituency engages policymakers within bodies such as the U.S. Congress and regulatory agencies like the Food and Drug Administration, and contributes to guideline discussions at forums convened by World Health Organization and UNAIDS. Advocacy campaigns have intersected with litigation and policy efforts involving stakeholders like Human Rights Watch and academic spaces including Yale University and Stanford University.

Impact and Contributions

The group has influenced consent language, community advisory practices, and enrollment policies reflected in trial protocols supported by National Institutes of Health and pharmaceutical partners like Pfizer. Its contributions echo through community-engaged research exemplified by partnerships with Kaiser Permanente research networks and implementation science projects funded by entities such as the National Institute of Mental Health. Program outcomes include enhanced representation of marginalized populations, improved retention metrics at sites like Grady Memorial Hospital, and dissemination of best practices at conferences hosted by the International AIDS Conference, Conference on Retroviruses and Opportunistic Infections, and professional societies including the Infectious Diseases Society of America.

Category:HIV/AIDS activism Category:Clinical trial organizations